Invention Grant
- Patent Title: Marker composition for diagnosing or predicting prognosis of lung cancer based on exosome overexpressing GCC2 gene or protein
-
Application No.: US17539030Application Date: 2021-11-30
-
Publication No.: US12000832B2Publication Date: 2024-06-04
- Inventor: Hyun Koo Kim , Sung Hoi Hong , Yong Park , Yeon Ho Choi , Ji Ho Park , Byeong Hyeon Choi , Hye Sun Jeong
- Applicant: KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION , KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY
- Applicant Address: KR Seoul
- Assignee: Korea University Research And Business Foundation,Korea Advanced Institute Of Science And Technology
- Current Assignee: Korea University Research And Business Foundation,Korea Advanced Institute Of Science And Technology
- Current Assignee Address: KR Seoul; KR Daejeon
- Agency: Armstrong Teasdale LLP
- Priority: KR 20170147510 2017.11.07
- The original application number of the division: US16762140
- Main IPC: C12Q1/6886
- IPC: C12Q1/6886 ; C07K16/30 ; G01N33/574
Abstract:
According to an embodiment of the present invention, a composition for diagnosing or predicting the prognosis of lung cancer is provided, the composition including a primer, probe, or antibody that specifically binds to a GRIP and coiled-coil domain-containing protein (GCC2) gene or protein in an exosome.
Public/Granted literature
Information query
IPC分类:
